Paul Campbell
Comptroller/Controller/Auditor at VIATRIS INC.
Net worth: 2 M $ as of 29/04/2024
Paul Campbell active positions
| Companies | Position | Start | End |
|---|---|---|---|
| VIATRIS INC. | Comptroller/Controller/Auditor | 15/11/2020 | - |
Career history of Paul Campbell
Former positions of Paul Campbell
| Companies | Position | Start | End |
|---|---|---|---|
Mylan NV
 Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | Comptroller/Controller/Auditor | - | - |
| Director of Finance/CFO | - | - |
Statistics
International
| United Kingdom | 2 |
| United States | 2 |
Operational
| Comptroller/Controller/Auditor | 2 |
| Director of Finance/CFO | 1 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| VIATRIS INC. | Health Technology |
| Private companies | 1 |
|---|---|
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Paul Campbell
- Experience
